Nina Zdinjak is a staff writer for Benzinga, a financial news and analysis platform. With a focus on the cannabis industry, Nina covers a wide range of topics including market trends, regulatory developments, and the impact of cannabis on various sectors. Her work has also been featured in Business Insider.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Nina Zdinjak's articles predominantly cover the medical marijuana and cannabis industry, with a focus on legal and regulatory developments. Her coverage suggests she may be interested in pitches from experts who can provide insights into government regulations, policy changes, or data-backed analysis related to medical marijuana legalization and its impact on healthcare and business sectors.
Given her focus on legal policy regulation (13%) and government announcements (23%), Nina is likely to appreciate contributions that shed light on legislative changes impacting the cannabis industry. Additionally, as her coverage includes citing data (15%), she might find value in pitches backed by credible statistics or research studies related to medical marijuana.
While Nina does not have a specific geographic focus mentioned, it's important for contributors reaching out to her to ensure their expertise aligns with global trends in medical marijuana legalization rather than being region-specific.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Nina Zdinjak
Zinger Key Points The DEA will move to reclassify marijuana as a less dangerous substance.
By: Nina Zdinjak
Zinger Key Points 'An Act Concerning Cannabis And Hemp Regulation' redefines high-THC hemp products, bans specific cannabis product advertising and more.
By: Nina Zdinjak
Schumer Says Marijuana Reclassification Is Necessary But Is Not End Of Story, Presents Bill To Federally ...
By: Nina Zdinjak
Scotts Miracle-Gro Marijuana-Focused Subsidiary Sales Decline 28%, CEO Confirms Deal In Works With RIV Capital ...
By: Nina Zdinjak
Teamsters Unionize Cannabis Workers At Another Cresco Labs' Dispensary In Illinois, 'It Feels Good' - Cresco Labs ...
By: Nina Zdinjak
Marijuana Ancillary Company Urban-Gro Quarterly Revenue Drops YoY, Improves Net Loss - Urban-gro (NASDAQ ...
By: Nina Zdinjak
Former FDA Agent Says Big Pharma Not Likely To Get Involved In Cannabis Industry After Rescheduling
By: Nina Zdinjak
Zinger Key Points Turning Point Brands reported first-quarter net sales of $97.1 million, compared to $100.96 million YoY.
By: Nina Zdinjak
Ascend Wellness Reports 5th Consecutive Quarter Of Positive Cash Flow While Net Debt Remains Around $238M ...
By: Nina Zdinjak
Cannabis Controls Patients' Pain While Improving Gastrointestinal And Pulmonary Function, Anesthesiologist ...
(833) 317-6278 
